230
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Dual drug nanocrystals loaded microparticles for fixed dose combination of simvastatin and ezetimibe

, &
Pages 40-53 | Received 15 Jul 2019, Accepted 15 Sep 2019, Published online: 24 Oct 2019

References

  • Anton N, Jakhmola A, Vandamme TF. 2012. Trojan microparticles for drug delivery. Pharmaceutics. 4(1):1–25.
  • Bandyopadhyay S, Katare OP, Singh B. 2012. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B: Biointerfaces. 100:50–61.
  • Bhatt V, Shete G, Bansal AK. 2015. Mechanism of generation of drug nanocrystals in celecoxib: mannitol nanocrystalline solid dispersion. Int J Pharm. 495(1):132–139.
  • Blaabjerg LI, Lindenberg E, Löbmann K, Grohganz H, Rades T. 2016. Glass forming ability of amorphous drugs investigated by continuous cooling and isothermal transformation. Mol Pharm. 13(9):3318–3325.
  • Burger A, Henck J-O, Hetz S, Rollinger JM, Weissnicht AA, Stöttner H. 2000. Energy/temperature diagram and compression behavior of the polymorphs of d‐mannitol. J Pharm Sci. 89(4):457–468.
  • Chaubal MV, Popescu C. 2008. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res. 25(10):2302–2308.
  • Forster A, Hempenstall J, Tucker I, Rades T. 2001. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm. 226(1–2):147–161.
  • Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. 2012. Drug nanocrystals: in vivo performances. J Control Release. 160(3):418–430.
  • Gulsun T, Gursoy RN, Oner L. 2011. Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull. 59(1):41–45.
  • Hintz R, Johnson K. 1989. The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm. 51(1):9–17.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 23(1–3):3–25.
  • Mizoe T, Ozeki T, Okada H. 2007. Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms. J Control Release. 122(1):10–15.
  • Mulye SP, Jamadar SA, Karekar PS, Pore YV, Dhawale SC. 2012. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique. Powder Technol. 222:131–138.
  • Ozkan Cansel K, Ozgur E, Sevinc K, Ayhan S, Sibel AO, Yalcin O. 2016. Development of a suitable dissolution method for the combined tablet formulation of atorvastatin and ezetimibe by RP-LC method. Curr Drug Deliv. 13(3):424–432.
  • Patel R, Bhimani D, Patel J, Patel D. 2008. Solid-state characterization and dissolution properties of ezetimibe–cyclodextrins inclusion complexes. J Incl Phenom Macrocycl Chem. 60(3–4):241–251.
  • Patravale V, Date AA, Kulkarni R. 2004. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 56(7):827–840.
  • Patterson A. 1939. The Scherrer formula for X-ray particle size determination. Phys Rev. 56(10):978.
  • Phanchaxari M, Kaushik S, Telsang S. 2011. Enhancement of solubility and dissolution property of griseofulvin by nanocrystallization. Int J Drug Dev Res. 3(2):180–191.
  • Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 3(9):785.
  • Sansone F, Aquino RP, Gaudio PD, Colombo P, Russo P. 2009. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. Eur J Pharm Biopharm. 72(1):206–213.
  • Sharma P, Denny WA, Garg S. 2009. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm. 380(1–2):40–48.
  • Shete G, Bansal AK. 2016. NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potential. Drug Deliv Transl Res. 6(4):392–398.
  • Shete G, Khomane KS, Bansal AK. 2014. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin. J Pharm Sci. 103(1):167–178.
  • Shete G, Modi SR, Bansal AK. 2015. Effect of mannitol on nucleation and crystal growth of amorphous flavonoids: implications on the formation of nanocrystalline solid dispersion. J Pharm Sci. 104(11):3789–3797.
  • Srivalli KMR, Mishra B. 2015. Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: effect of P-gp inhibitory stabilizer on particle size and oral absorption. Colloids Surf B: Biointerfaces. 135:756–764.
  • Taupitz T, Dressman JB, Klein S. 2013. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm. 84(1):208–218.
  • Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P, Van Den Mooter G. 2008. Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. Eur J Pharm Sci. 35(4):344–353.
  • Van Eerdenbrugh B. 2009. A screening study of surface stabilization during the production of drug nanocrystals. Int J Pharm. 98(6):2091–2103.
  • Van Krevelen DW, Nijenhuis KT. 2009. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. Elsevier.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.